Publications by authors named "Jason Kato"

Claim this Profile
T
The HB22.7-vcMMAE antibody-drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicity.
Mastewal Abuhay, Jason Kato, Emily Tuscano, Gustavo A Barisone, Ranjit S Sidhu

Cancer Immunol Immunother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Discovery of Functional Small Molecule Ligands against Proteomic Targets through Library-Against-Library Screening.
Chun-Yi Wu, Don-Hong Wang, Xiaobing Wang, Seth M Dixon, Liping Meng, Jason Kato

ACS Comb Sci· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a CD22-targeted antibody-saporin conjugate in a xenograft model of precursor-B cell acute lymphoblastic leukemia.
Jason Kato, Noriko Satake, Robert T O'Donnell, Mastewal Abuhay, Carly Lewis

Leuk Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and toxicity of a CD22-targeted antibody-saporin conjugate in a xenograft model of non-Hodgkin's lymphoma.
Jason Kato, Robert T O'Donnell, Mastewal Abuhay, Joseph M Tuscano

Oncoimmunology· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD22 antigen is broadly expressed on lung cancer cells and is a target for antibody-based therapy.
Joseph M Tuscano, Jason Kato, David Pearson, Chengyi Xiong, Laura Newell

Cancer Res· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disulfide cross-linked micelles for the targeted delivery of vincristine to B-cell lymphoma.
Jason Kato, Yuanpei Li, Kai Xiao, Joyce S Lee, Juntao Luo

Mol Pharm· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery.
Yuanpei Li, Kai Xiao, Juntao Luo, Wenwu Xiao, Joyce S Lee, Jason Kato

Biomaterials· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Bs20x22 anti-CD20-CD22 bispecific antibody has more lymphomacidal activity than do the parent antibodies alone.
Joseph M Tuscano, Yunpeng Ma, Shiloh M Martin, Jason Kato, Robert T O'Donnell

Cancer Immunol Immunother· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis